Taipei, Taiwan

Yu-Chien Chen

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Taipei Medical University. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yu-Chien Chen. Retrieved from https://idiyas.com/inventor/yu-chien-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Yu-Chien Chen in Diabetes Treatment

Introduction

Yu-Chien Chen is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of diabetes treatment through his innovative research and patenting efforts. His work focuses on methods for controlling blood glucose levels and addressing complications associated with diabetes mellitus.

Latest Patents

Yu-Chien Chen holds a patent titled "Hypoglycemic activity of osthole." This invention relates to a method for controlling blood glucose levels and provides a formulation for the prophylaxis or treatment of diabetes mellitus and its complications. The patent highlights the potential of osthole as an effective anti-diabetic agent.

Career Highlights

Yu-Chien Chen is affiliated with Taipei Medical University, where he conducts research and develops innovative solutions for diabetes management. His dedication to improving health outcomes for individuals with diabetes is evident in his patent and ongoing research efforts.

Collaborations

Some of his coworkers include Yu-Chih Liang and Der-Zen Liu, who contribute to the collaborative research environment at Taipei Medical University. Their combined expertise enhances the potential for groundbreaking advancements in diabetes treatment.

Conclusion

Yu-Chien Chen's innovative work in diabetes treatment through his patent demonstrates his commitment to addressing critical health challenges. His contributions are paving the way for new therapeutic options in managing diabetes and improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…